Femme et Homme
- | Pays :
- Netherlands
- Greece
- Australia
- Les 8 autres...
- | Organes : -
- | Spécialités : -
Extrait
At the conclusion of study AZA PH GL 2003 CL 001 (NCT00071799), eligible participants could be enrolled in an optional extension phase in order to continue treatment with azacitidine until it became commercially available; the continued treatment was for ethical and safety reasons only and not to provide additional efficacy data.
Critère d'inclusion
- Myelodysplastic syndromes